Straumann Holding Ag · SIX:STMN
Straumann — Q1 2015 Earnings Presentation
18 slides from Straumann's earnings presentation, Apr 30, 2015
Slide 1: 2015 First-quarter revenue Conference Call
2015 First-quarter revenue Conference Call Basel, 30 April 2015 Disclaimer This presentation contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results
Slide 2: Q1 Highlights
Q1 Highlights Marco Gadola, CEO Good start to 2015 REVENUE Q1 REVENUE GROWTH KEY DRIVERS North America and CHF 193m +8% organic 1 APAC Including CHF 7m contribution from Performance reflects investments in Double-digit expansion (organic) in Neodent following full consolidation growth markets/segmen
Slide 3: Neodent: undisputed leader in Brazil
Neodent: undisputed leader in Brazil Brazilian implant market: Approx. 40% domestic market share 2.3m implant units sold in 20142 Good reputation for customer focus/service; Nobel Biocare high-quality perception among Brazilian Zimmer Biomet 3i dentists Others Strong on education with ILAPEO1,
Slide 4: Neodent - an expanding global presence; new market share situation
Neodent - an expanding global presence Availablity of Neodent products through: Own subsidiaries, Instradent and 3rd party distributors Future roll-outs 7 The new market share situation Global dental implant & abutment market worth CHF 3bn (2014 pro-forma) Others 26% 24% 7% 20% 13% 10% 8 Based on iD
Slide 5: Business and regional performance
Business and regional performance Peter Hackel, CFO Regenerative sales complement robust growth in implants Implants Restorative Regeneratives 10 5
Slide 6: North America: Double-digit growth outside EMEA
Double-digit growth outside EMEA In CHF million, rounded 7.4% in CHF 8.2% organic 1.3 7.4 0.3 5.6 (7.8) 6.7 193.2 179.8 178.6 Organic growth (4.4%) 3.9% 0.3% 11.6% 34.5% 11.7% Revenue Q1 FX Effect Acquisition Adj. revenue EMEA North APAC LATAM Revenue Q1 2014 Effect Q1 2014 America 2015 2014 2015 11
Slide 7: Asia Pacific LATAM: Dynamic China and continued good performance
Dynamic China and continued good performance in Latin America Revenue change (organic) Exceptional growth in China due to Asia Pacific 34.5% stocking by new dealers 15% 56% Growth in Japan expectedly below 15.3% 17.0% 14.5% prior Q1 (SLActive launch; stocking 8.3% before April VAT increase) Ro
Slide 8: Neodent key figures
Neodent key figures Experience Revenue 2014 Revenue growth 2014 (l.c.) BRL 258m 12% worldwide 22y history CHF 101m 1 8% domestic Founded 1993 Leading implant company in LATAM Robust growth and further share gains in domestic market despite challenging economy Outlook 2015 Highly profitable Employees
Slide 9: Details of the Neodent accounting
Details of the Neodent accounting Neodent consolidation will trigger fair-value adjustments PPA and opening balance to be finalized; amortization charges may still vary until completion: OPEX Amortization of intangible assets (approx. CHF 7m1 p.a. over 7 years) One-time effects: COGS Inven
Slide 10: Separate brand strategy to address premium and value segments
Separate brand strategy to address premium and value segments Germany Spain Brazil Germany (Option 30%) (30%) (100%) (51%) Canada Germany Taiwan S. Korea (44%) (100%) (Convertible) (Convertible) US Taiwan (13%) Austria (49%) Switzerland (44%) Common production & Premium technology platform Value 19
Slide 11: New solutions presented at key trade events
New solutions presented at key trade events Straumann launches holistic prosthetics campaign targeted at dental labs worldwide 22 11
Slide 12: Strong presence at Chicago Midwinter, AO & IDS events
Strong presence at Chicago Midwinter, AO & IDS events with special focus on labs New visitor record (138 500) in Cologne Straumann booth at the IDS Dental Wings’ new intra-oral scanner… and laser mill Straumann booth at the AO 23 More information on Straumann at the IDS ‘Analyst talk’ – video interv
Slide 13: Strengthened position in lab segment; digital equipment solutions
Strengthened position in lab segment with original-on-original components Variobase® abutment family CARES® X-Stream™ (also for the CEREC workflow) bridge-and-bar solutions Straumann® pre-milled abutment blanks Innovative prosthetic retention system by Valoc 3M™ ESPE™ Lava™ Plus high translucency zi
Slide 14: Bone Level Tapered roll-out; total solution provider strategy
Bone Level Tapered implant roll-out underway 2014 2015 2016 2017 Q3 Q4 Q1 Q2 Q3 Q4 Q1-Q4 Q1-Q4 EMEA - Germany, Austria & Switzerland CMR FMR - Europe (outside DACH) CMR FMR - Distributors CMR FMR N o r t h Am e r i c a CMR FMR As i a P a c i f i c - Japan1,2 FMR2 - China1,2 CMR - Distributors1 CMR F
Slide 15: Outlook 2015 / Questions & Answers
Outlook 2015 Barring unforeseen circumstances Further improvement in global implant market expected. Revenue expected to grow organically in mid-single-digit range. Further investments in strategic growth markets and projects Cost reduction measures including compensation reductions in CH, hir
Slide 16: Re-categorization of the 2014 regional revenues
Re-categorization1 of the 2014 regional revenues REVENUE BY REGION (in CHF millio n) Q1 2015 Q1 2014 FY 2014 EMEA 98.6 107.7 389.2 Change in CHF in % (8.4%) 5.4% 2.2% Change in local currencies in % 0.3% 5.5% 3.2% North America 53.7 45.5 193.1 Change in CHF in % 18.1% 0.5% 6.3% Change in local curre
Slide 17: Straumann's production footprint; Your contacts
Straumann’s production foot-print Andover (USA): Malmö (S): Implant production Regenerative products Leipzig (D): CADCAM milling Villeret (CH): Arlington (USA): Implant production CADCAM milling Curitiba (BR): Implant production Straumann Your contacts Fabian Hildbrand Corporate Investor Relations
Slide 18: International Headquarters
International Headquarters Institut Straumann AG Peter Merian-Weg 12 CH-4002 Basel, Switzerland Phone +41(0)61 965 11 11 Fax +41(0)61 965 10 01 www.straumann.com 18